pipette
ESEspañol

Longitudinal Investigation of Autonomic Symptoms in Biologically Confirmed (SAA+) Parkinson's Disease

A. A. Memon, S. H. Choi, J. Yin, D.-E. Lafontant, C. Caspell-Garcia, D. Weintraub, A. W. Amara, M. Picillo

PreprintReal-world use

In the authors' words

Background Autonomic symptoms are common in Parkinson disease (PD) and impact quality of life, with unclear relationship to motor and cognitive progression. Objective: Characterize five-year progression of autonomic symptoms in early PD and their association with motor and cognitive outcomes. Methods We analyzed data from 874 PD participants and 252 healthy controls (HC) enrolled in Parkinson Progression Markers Initiative (PPMI). Autonomic symptoms were assessed annually over five years using Scales for Outcomes in Parkinson's disease-Autonomic dysfunction (SCOPA-AUT); affected autonomic domains were defined as domain subscore >1. Clinical measures included MDS-UPDRS and Montreal Cognitive Assessment. Generalized estimating equations evaluated longitudinal changes, adjusting for age, sex, medication, and comorbidities. Results: At baseline, 71% of PD participants reported >1 affected autonomic domain, increasing to 85% among 287 PD participants with 5-year follow-up; HCs reporting >1 affected autonomic domain increased from 40% of participants at baseline to 46% among 145 participants with 5-year follow-up. Gastrointestinal and urinary symptoms were most prevalent in PD. Medication use for constipation and urinary dysfunction increased over time in PD. Cardiovascular comorbidities were common and increased in prevalence in both groups. Greater baseline autonomic symptom burden predicted more rapid cognitive, but not motor decline in PD (p=0.002). Conclusion: Autonomic symptoms in PD are common at disease onset, near universal after 5 years, and associated with faster cognitive, but not motor, decline, driven by those with severe symptoms. The high prevalence and impact of autonomic symptoms in early PD highlights the importance of early assessment and management of these symptoms.

Main resultThe abstract does not state a limitation.

Appeared: Tuesday, November 10. medRxiv. Preprint, not yet peer-reviewed.

DOI: 10.64898/2026.11.09.26367184